0

Synthesis and Pharmacological Evaluation of 2-(1-alkylpiperidin-4-yl)-n-[(1r)-1-(4-fluorophenyl)-2-methylpropyl]acetamide Derivatives as Novel Antihypertensive Agents

Susumu Watanuki, Keisuke Matsuura, Yuichi Tomura, Minoru Okada, Toshio Okazaki, Mitsuaki Ohta, Shin-ichi Tsukamoto

Chem Pharm Bull (Tokyo). 2012;60(2):223-34.

PMID: 22293482

Abstract:

We synthesized and evaluated the inhibitory activity of a series of 2-(1-alkylpiperidin-4-yl)-N-[(1R)-1-(4-fluorophenyl)-2-methylpropyl]acetamide derivatives against T-type Ca(2+) channels. Structure-activity relationship studies revealed that the position of the amide structure was important for the potent inhibitory activity toward T-type Ca(2+) channels. In addition, the introduction of an appropriate substituent on the pendant benzene ring played a crucial role for the selectivity towards T-type Ca(2+) channels over L-type Ca(2+) channels and the potent bradycardic activity of these derivatives. Oral administration of N-[(1R)-1-(4-fluorophenyl)-2-methylpropyl]-2-(1-{2-[2-(2-methoxyethoxy)phenyl]ethyl}piperidin-4-yl)acetamide (4f), which had superior selectivity for T-type Ca(2+) channels over L-type Ca(2+) channels, lowered blood pressure in spontaneously hypertensive rats without inducing reflex tachycardia, which is often caused by traditional L-type Ca(2+) channel blockers.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
LS793963 [4-(2-methoxyethoxy)phenyl]boranediol [4-(2-methoxyethoxy)phenyl]boranediol Price
qrcode